# Church & Dwight Co Inc: Form 10-Q for the period ended Sep 30, 2014

- Company: [Church & Dwight Co Inc](/companies/chd.md) (CIK 313927)
- Form: 10-Q
- Filed: 2014-11-03
- Accepted by EDGAR: Nov 3, 2014, 19:02 ET
- Period: 2014-09-30
- Accession: 0001564590-14-004859
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/313927/000156459014004859/chd-10q_20140930.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/313927/000156459014004859/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2014-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2014-07-01 to 2014-09-30 | $841.8m | us-gaap:SalesRevenueGoodsNet |
| Revenue | 9 months, 2014-01-01 to 2014-09-30 | $2.43bn | us-gaap:SalesRevenueGoodsNet |
| Cost of revenue | 3 months, 2014-07-01 to 2014-09-30 | $474.3m | us-gaap:CostOfGoodsSold |
| Cost of revenue | 9 months, 2014-01-01 to 2014-09-30 | $1.37bn | us-gaap:CostOfGoodsSold |
| Gross profit | 3 months, 2014-07-01 to 2014-09-30 | $367.5m | us-gaap:GrossProfit |
| Gross profit | 9 months, 2014-01-01 to 2014-09-30 | $1.06bn | us-gaap:GrossProfit |
| Research and development | 3 months, 2014-07-01 to 2014-09-30 | $14.8m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months, 2014-01-01 to 2014-09-30 | $42.3m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months, 2014-07-01 to 2014-09-30 | $93.7m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months, 2014-01-01 to 2014-09-30 | $288.1m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2014-07-01 to 2014-09-30 | $177.2m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2014-01-01 to 2014-09-30 | $477.4m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2014-07-01 to 2014-09-30 | $6.9m | us-gaap:InterestExpense |
| Interest expense | 9 months, 2014-01-01 to 2014-09-30 | $20.5m | us-gaap:InterestExpense |
| Income tax | 3 months, 2014-07-01 to 2014-09-30 | $57.3m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2014-01-01 to 2014-09-30 | $157.6m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 9 months, 2014-01-01 to 2014-09-30 | $307.3m | us-gaap:ProfitLoss |
| Diluted EPS | 3 months, 2014-07-01 to 2014-09-30 | $0.85 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months, 2014-01-01 to 2014-09-30 | $2.23 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2014-07-01 to 2014-09-30 | $0.87 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months, 2014-01-01 to 2014-09-30 | $2.27 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2014-07-01 to 2014-09-30 | 136,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months, 2014-01-01 to 2014-09-30 | 137,900,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months, 2014-01-01 to 2014-09-30 | $408.7m | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Capital expenditure | 9 months, 2014-01-01 to 2014-09-30 | $36.2m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months, 2014-01-01 to 2014-09-30 | $126.0m | us-gaap:PaymentsOfDividends |
| Share repurchases | 9 months, 2014-01-01 to 2014-09-30 | $435.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2014-09-30 | $370.2m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2014-09-30 | $992.8m | us-gaap:AssetsCurrent |
| Total assets | at 2014-09-30 | $4.33bn | us-gaap:Assets |
| Current liabilities | at 2014-09-30 | $918.4m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2014-09-30 | $2.24bn | us-gaap:Liabilities |
| Long-term debt | at 2014-09-30 | $649.6m | us-gaap:LongTermDebtNoncurrent |
| Short-term borrowings | at 2014-09-30 | $404.1m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | at 2014-09-30 | $2.09bn | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 24,384 characters.

### RESULTS OF OPERATIONS

### Results of Operations

### Consolidated results

#### Net Sales

Net sales for the quarter ended September 30, 2014 were $841.8, an increase of $37.0 or 4.6% over the third quarter of 2013. Net sales for the nine months ended September 30, 2014 were $2,432.1, an increase of $60.4 or 2.5% over the comparable nine month period of 2013. The components of the net sales increase are as follows:

| Net Sales - Consolidated | Three Months Ended September 30, 2014 | Nine Months Ended September 30, 2014 |
| --- | ---: | ---: |
| Product volumes sold | 5.2% | 4.4% |
| Pricing/Product mix | (0.5%) | (1.4%) |
| Foreign exchange rate fluctuations | 0.0% | (0.3%) |
| Acquired product lines(1) | 0.1% | 0.0% |
| Divested product lines | (0.2%) | (0.2%) |
| **Net Sales increase** | **4.6%** | **2.5%** |

(1) On September 19, 2014, the Company acquired certain feminine care brands from Lil’ Drug Store Products Inc. (“Lil’ Drug Store Brands Acquisition”). Net sales of the brands acquired in the Lil’ Drug Store Brands Acquisition are included in the Company’s results since the date of acquisition.

For the three months ended September 30, 2014, the volume change primarily reflects increased product sales in all segments. Unfavorable price/mix in Consumer Domestic and Consumer International, primarily due to higher trade spending, was partially offset by favorable price/mix in SPD. For the nine months ended September 30, 2014, unfavorable price/mix in Consumer Domestic, primarily due to new product introductory costs, and Consumer International was partially offset by favorable price/mix in SPD.

#### Gross Profit

The Company’s gross profit was $367.5 for the quarter ended September 30, 2014, a $2.3 increase as compared to the same period in 2013 due primarily to higher sales volume partially offset by higher commodity costs and trade promotion spending. The Company’s gross profit was $1,063.3 for the nine month period ended September 30, 2014, a $3.0 decrease as compared to the same period in 2013 due to the effect of the costs associated with new product launches and higher commodity costs, partially offset by higher sales volumes. Gross margin decreased 170 basis points to 43.7% in the third quarter of 2014 as compared to 45.4% in same period in 2013, and gross margin decreased 130 basis points to 43.7% in the first nine months of 2014 as compared to 45.0% in the same period of 2013. Gross margin was lower due to higher trade promotion, coupon, slotting and commodity costs, partially offset by the positive impact of productivity improvement programs.

#### Operating Costs

Marketing expenses for the third quarter of 2014 were $96.6, a decrease of $3.1 as compared to the same period in 2013. In the third quarter of 2014, higher marketing costs associated with introductory products were offset by lower costs on other brands. Marketing expenses as a percentage of net sales were 11.5% in the third quarter of 2014 as compared to 12.4% in the same period in 2013. Marketing expenses for the first nine months of 2014 were $297.8, an increase of $15.5 as compared to the same period in 2013 due primarily to expenses in support of new product launches and increased expenses in certain other power brands. Marketing expenses as a percentage of net sales were 12.2% in the first nine months of 2014 as compared to 11.9% in the same period in 2013.

Selling, general and administrative (“SG&A”) expenses were $93.7 in the third quarter of 2014, a decrease of $4.0 as compared to the same period in 2013 due primarily to lower compensation and benefit costs and research and development costs recorded in the current period, and cease use charges recorded in 2013 associated with the Company’s Princeton leased buildings, partially offset by higher litigation costs. SG&A for the first nine months of 2014 were $288.1, a decrease of $18.3 as compared to the same period in

2013 due primarily to lower compensation costs and research and development costs partially offset by a $5.0 intangible asset impairment charge. Additionally, in 2013 the Company incurred costs related to the integration of the gummy dietary supplements business and recorded cease use charges associated with the Company’s Princeton leased buildings. SG&A as a percentage of net sales was 11.1% in the third quarter of 2014 as compared to approximately 12.2% in the same period in 2013. SG&A as a percentage of net sales was 11.9% in the first nine months of 2014 as compared to approximately 13.0% in the same period in 2013.

#### Other Income and Expenses

Equity in earnings of affiliates increased by $1.5 and $6.5 for the three and nine month periods ended September 30, 2014, respectively, as compared to the same periods in 2013. The increase in earnings was due primarily to profit improvement from Armand and lower expenses at Natronx. Also, in the second quarter of 2013, the Company recorded an impairment charge associated with one of its affiliates.

Other expense increased $1.0 million in the current quarter due to the effect of changes in foreign currencies.

Interest expense in the three and nine month periods ended September 30, 2014 decreased $0.1 and $0.5, respectively, compared to the same periods in 2013.

#### Taxation

The effective tax rate in the three and nine month periods ended September 30, 2014 was 33.1% and 33.9% respectively, compared to 33.9% and 34.1% respectively, in the same periods in 2013. The reduction in the current quarter rate is primarily due to the impact of favorable discrete adjustments related to uncertain income tax positions. The 2014 annual effective tax rate is projected to be approximately 34%.

### Segment results

The Company operates three reportable segments: Consumer Domestic, Consumer International and SPD. These segments are determined based on differences in the nature of products and organizational and ownership structures. The Company also has a Corporate segment.

| Segment | Products |
| --- | --- |
| Consumer Domestic | Household and personal care products |
| Consumer International | Primarily personal care products |
| SPD | Specialty chemical products |

The Corporate segment income consists of equity in earnings (losses) of affiliates. As of September 30, 2014, the Company held 50% ownership interests in each of Armand and ArmaKleen, respectively, and a one-third ownership interest in Natronx. The Company’s equity in earnings (losses) of Armand, ArmaKleen and Natronx for the three and nine month periods ended September 30, 2014 and September 30, 2013 are included in the Corporate segment.

Some of the subsidiaries that are included in the Consumer International segment manufacture and sell personal care products to the Consumer Domestic segment. These sales are eliminated from the Consumer International segment results set forth below.

Segment net sales and income before income taxes for the three and nine month periods ended September 30, 2014 and September 30, 2013 are as follows:

| Net Sales(1) | Consumer Domestic | Consumer International | SPD | Corporate(3) | Total |
| --- | ---: | ---: | ---: | ---: | ---: |
| **Third Quarter 2014** | **$627.2** | **$136.2** | **$78.4** | **$0.0** | **$841.8** |
| Third Quarter 2013 | 605.3 | 134.5 | 65.0 | 0.0 | 804.8 |
| **First Nine Months of 2014** | **$1,819.4** | **$396.6** | **$216.1** | **$0.0** | **$2,432.1** |
| First Nine Months of 2013 | 1,790.8 | 396.5 | 184.4 | 0.0 | 2,371.7 |
| **Income before Income Taxes(2)** |  |  |  |  |  |
| **Third Quarter 2014** | **$141.4** | **$15.0** | **$13.4** | **$3.4** | **$173.2** |
| Third Quarter 2013 | 136.0 | 15.5 | 9.8 | 1.9 | 163.2 |
| **First Nine Months of 2014** | **$376.0** | **$47.5** | **$33.5** | **$7.9** | **$464.9** |
| First Nine Months of 2013 | 383.2 | 53.0 | 21.0 | 1.4 | 458.6 |

(1) Intersegment sales from Consumer International to Consumer Domestic, which are not reflected in the table, were $0.3 and $0.7 for the quarter ended September 30, 2014 and September 30, 2013, respectively, and $0.8 and $1.9 for the nine months ended September 30, 2014 and September 30, 2013, respectively.

(2) In determining Income before Income Taxes, interest expense, investment earnings, and other income (expense) were allocated among the segments based upon each segment’s relative Income from Operations.

(3) Corporate segment consists of equity in earnings (losses) of affiliates from Armand, ArmaKleen and Natronx.

Product line revenues from external customers are as follows:

|  | Three Months Ended September 30, 2014 | September 30, 2013 | Nine Months Ended September 30, 2014 | September 30, 2013 |
| --- | ---: | ---: | ---: | ---: |
| Household Products | **$379.5** | $369.0 | **$1,087.2** | $1,081.8 |
| Personal Care Products | **247.7** | 236.3 | **732.2** | 709.0 |
| Total Consumer Domestic | **627.2** | 605.3 | **1,819.4** | 1,790.8 |
| Total Consumer International | **136.2** | 134.5 | **396.6** | 396.5 |
| Total SPD | **78.4** | 65.0 | **216.1** | 184.4 |
| **Total Consolidated Net Sales** | **$841.8** | $804.8 | **$2,432.1** | 2,371.7 |

Household Products include laundry, deodorizing, and cleaning products. Personal Care Products include condoms, pregnancy kits, oral care products, skin care products and gummy dietary supplements.

### Consumer Domestic

Consumer Domestic net sales in the third quarter of 2014 were $627.2, an increase of $21.9 or 3.6% as compared to the same period in 2013. Consumer Domestic net sales for the nine months ended September 30, 2014 were $1,819.4, an increase of $28.6 or 1.6% as compared to the same period in 2013. The components of the net sales change are the following:

| Net Sales - Consumer Domestic | Three Months Ended September 30, 2014 | Nine Months Ended September 30, 2014 |
| --- | ---: | ---: |
| Product volumes sold | 4.3% | 3.4% |
| Pricing/Product mix | (0.8%) | (1.8%) |
| Acquired product lines(1) | 0.1% | 0.0% |
| **Net Sales increase** | **3.6%** | **1.6%** |

(1) Includes net sales of the brands acquired in the Lil’ Drug Store Brands Acquisition since the date of acquisition.

In the third quarter of 2014, the increase in net sales reflects higher sales for the recently introduced ARM & HAMMER CLUMP & SEAL cat litter and OXICLEAN liquid laundry detergent, and higher sales for TROJAN condoms and VITAFUSION gummy dietary supplements, partially offset by declining sales in XTRA laundry detergent, L’IL CRITTER gummy dietary supplements and ARM & HAMMER unit dose and powder laundry detergents. The increase in net sales for the nine months ended September 30, 2014 includes the new product launches of ARM & HAMMER CLUMP & SEAL cat litter and OXICLEAN liquid laundry detergent, and higher sales of OXICLEAN laundry additive products, TROJAN products, VITAFUSION gummy dietary supplements and NAIR depilatories, partially offset by declining sales in XTRA laundry detergent, L’IL CRITTER gummy dietary supplements and ARM & HAMMER laundry detergent.

Since the 2012 introduction in the U.S. of unit dose laundry detergent by various manufacturers, including the Company, there has been significant product and price competition in the laundry detergent category, contributing to an overall category decline. During 2013, the category declined by 3.2%. In 2014, the Procter & Gamble Company, one of the Company’s major competitors and the market leader in laundry detergent, has taken several competitive actions, including launching a lower-priced laundry detergent that competes directly with the Company’s core value laundry detergents. This, together with expected ongoing weak consumer spending and aggressive price competition by other laundry competitors, has negatively impacted the Company’s laundry detergent business. Over the last twelve months, the category declined 3.0%. The Company is vigorously combating these pressures through, among other things, significant new product introductions and increased marketing spending. There is no assurance that the category will not decline further and that the Company will be able to offset any such category decline.

Consumer Domestic income before income taxes for the third quarter of 2014 was $141.4, a $5.4 increase as compared to the third quarter of 2013. The increase is due primarily to the impact of higher sales volumes, manufacturing costs savings resulting from productivity improvement projects and lower marketing and SG&A costs, partially offset by higher trade promotion spending and higher commodity costs. For the nine month period ended September 30, 2014, income before income taxes was $376.0, a $7.2 decrease as compared to the first nine months of 2013 due to introductory trade promotion, coupon and marketing costs in support of new product launches, higher commodity costs and a $5.0 intangible asset impairment charge, partially offset by the impact of higher sales volumes, manufacturing costs savings resulting from productivity improvement projects and lower marketing and SG&A costs.

### Consumer International

Consumer International net sales were $136.2 in the third quarter of 2014, an increase of $1.7 or 1.3% as compared to the same period in 2013. Consumer International net sales in the first nine months of 2014 were $396.6, an increase of $0.1 as compared to the same period in 2013. The components of the net sales change are the following:

| Net Sales - Consumer International | Three Months Ended September 30, 2014 | Nine Months Ended September 30, 2014 |
| --- | ---: | ---: |
| Product volumes sold | 3.1% | 2.4% |
| Pricing/Product mix | (1.4%) | (0.5%) |
| Foreign exchange rate fluctuations | 0.1% | (1.3%) |
| Divested product lines | (0.5%) | (0.6%) |
| **Net Sales increase (decrease )** | **1.3%** | 0.0% |

Higher sales in the third quarter of 2014 occurred primarily in Mexico, the United Kingdom and Brazil, offset by lower U.S. exports and lower sales in Canada. Sales were flat in the first nine months of 2014 due to higher sales in the United Kingdom, Mexico, Brazil and France, offset by lower U.S. exports and lower sales in Canada.

Consumer International income before income taxes was $15.0 in the third quarter of 2014, a decrease of $0.5 compared to the same period in 2013 due primarily to the effect of foreign exchange rate changes and higher marketing expenses. For the first nine months of 2014, income before income taxes was $47.5, a $5.5 decrease as compared to the same period of 2013, due primarily to the same factors as those applicable to the third quarter of 2014.

### Specialty Products

SPD net sales were $78.4 for the third quarter of 2014, an increase of $13.4 or 20.6% as compared to the same period in 2013. SPD net sales were $216.1 for the first nine months of 2014, an increase of $31.7 or 17.2% as compared to the same period of 2013. The components of the net sales change are the following:

| Net Sales - SPD | Three Months Ended September 30, 2014 | Nine Months Ended September 30, 2014 |
| --- | ---: | ---: |
| Product volumes sold | 18.2% | 18.2% |
| Pricing/Product mix | 3.9% | 1.1% |
| Foreign exchange rate fluctuations | 0.0% | (1.0)% |
| Divested product lines | (1.5)% | (1.1)% |
| **Net Sales increase** | **20.6%** | **17.2%** |

The net sales increase in the third quarter of 2014 reflects higher sales volume of animal nutrition products and performance products. The animal nutrition business’s strong performance is primarily related to the strength of the U.S. dairy industry, which has experienced high milk prices and low input commodity costs, prompting dairy producers to feed more animal nutrition products and produce higher volumes of milk per cow. The increase in net sales for the nine months ended September 30, 2014 is due primarily to the same factors as those applicable to the third quarter of 2014.

SPD income before income taxes was $13.4 in the third quarter of 2014, an increase of $3.6 as compared to the same period in 2013, and was $33.5 for the first nine months of 2014, an increase of $12.5 as compared to the same period in 2013. The increase in income before income taxes in the three and nine month periods of 2014 is due primarily to higher sales volume and sales prices and lower SG&A costs. Manufacturing costs were higher in the three months ended September 30, 2014 as compared to the same period in 2013, but were slightly lower than the prior year for the nine months ended September 30, 2014.

### Corporate

The Corporate segment reflects the equity in earnings (losses) of affiliates from Armand, ArmaKleen and Natronx. The Corporate segment income before income taxes was $3.4 in the third quarter of 2014, an increase of $1.5 as compared to the same period in 2013. The Corporate segment income before income taxes was $7.9 for the first nine months of 2014, an increase of $6.5 as compared to the same period in 2013. In the second quarter of 2013 the Company recorded an impairment charge associated with one of its affiliates.

### Liquidity and capital resources

As of September 30, 2014, the Company had $370.2 in cash and cash equivalents, approximately $100 available through the revolving facility under its principal credit agreement (“Credit Agreement”) and its commercial paper program, and a commitment increase feature under the Credit Agreement that enables the Company to borrow up to an additional $500, subject to lending commitments of the participating lenders and certain conditions as described in the Credit Agreement. To preserve its liquidity, the Company invests its cash primarily in prime money market funds and short term bank deposits.

As of September 30, 2014, the amount of cash and cash equivalents included in the Company’s assets, that was held by foreign subsidiaries was $242.8. If these funds are needed for operations in the U.S., the Company will be required to accrue and pay taxes in the U.S. to repatriate these funds. However, the Company’s intent is to permanently reinvest these funds outside the U.S., and the Company does not currently expect to repatriate them to fund operations in the U.S.

The current economic environment presents risks that could have adverse consequences for the Company’s liquidity. (See “Unfavorable economic conditions could adversely affect demand for the Company’s products” under “Risk Factors” in Item 1A of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2013 (the “Form 10-K”).) The Company does not anticipate that current economic conditions will adversely affect its ability to comply with the financial covenants in the Credit Agreement because the Company currently is, and anticipates that it will continue to be, in compliance with the minimum interest coverage ratio requirement and the maximum leverage ratio requirement under the Credit Agreement. These financial ratios are discussed in more detail in this section under “Certain Financial Covenants.”

On January 29, 2014, the Company’s board of directors (“the Board”) authorized a new share repurchase program, under which the Company may repurchase up to $500 of its common stock (“Common Stock”). This share repurchase program replaced the

Company’s share repurchase program previously announced on November 5, 2012. In addition, the Board authorized a new evergreen share repurchase program, under which the Company may repurchase, from time to time, Common Stock to reduce or eliminate dilution associated with issuances of Common Stock under the Company’s incentive plans.

As part of the new share repurchase programs, in the first nine months of 2014 the Company entered into accelerated share repurchase (“ASR”) contracts with a commercial bank to purchase approximately 6.4 million shares of Common Stock for $435, of which $74 was purchased under the evergreen program and $361 was purchased under the share repurchase program. As a result of these purchases, there remains $139 under the share repurchase program.

The Company anticipates that its available cash and cash from operations will be sufficient to meet its capital expenditure program costs, which are expected to be approximately $70.0 in 2014, fund its share repurchase program to the extent implemented by management and pay dividends at the latest approved rate. Cash, together with the Company’s current borrowing capacity, may be used for acquisitions that would complement the Company’s existing product lines or geographic markets. The Company does not have any mandatory fixed rate debt principal payments in 2014.

#### Net Debt

The Company had outstanding total debt of $1,053.7 and cash of $370.2, resulting in net debt of $683.5 at September 30, 2014. This compares to total debt of $803.3 and cash of $496.9, resulting in net debt of $306.4 at December 31, 2013. Net debt is defined as the sum of short-term debt and long-term debt, minus cash and cash equivalents.

#### Cash Flow Analysis

|  | Nine Months Ended September 30, 2014 | September 30, 2013 |
| --- | ---: | ---: |
| Net cash provided by operating activities | **$408.7** | $376.6 |
| Net cash used in investing activities | **$(253.6)** | $(39.1) |
| Net cash used in financing activities | **$(271.6)** | $(230.0) |

**Net Cash Provided by Operating Activities –** The Company’s net cash provided by operating activities in the first nine months of 2014 increased by $32.1 to $408.7 as compared to the same period in 2013 due to higher net income. Net cash provided by operating activities in 2013 was negatively affected by the deferred payment of the fourth quarter 2012 federal tax obligation of $36.0 as allowed by the IRS due to the impact of Hurricane Sandy.

**Net Cash Used in Investing Activities –** Net cash used in investing activities during the first nine months of 2014 was $253.6, principally reflecting the $216.1 paid for the Lil’ Drug Store Brands Acquisition, and $36.2 for property, plant and equipment expenditures.

**Net Cash Used in Financing Activities –** Net cash used in financing activities during the first nine months of 2014 was $271.6, primarily reflecting $435.0 of repurchases of Common Stock, $126.0 of cash dividends offset by an increase in short-term debt of $250.4 to fund the Lil’ Drug Store Brands Acquisition and $39.1 of proceeds and tax benefits from stock option exercises.

### Certain Financial Covenants

“Consolidated EBITDA” (referred to below as “Adjusted EBITDA” and defined in the Credit Agreement) is a component of the financial covenants contained in the Credit Agreement. Such financial covenants include a leverage ratio (total debt to Adjusted EBITDA) and an interest coverage ratio (Adjusted EBITDA to total interest expense), which, if not met, could result in an event of default and trigger the early termination of the Credit Agreement. Adjusted EBITDA may not be comparable to similarly titled measures used by other entities and should not be considered as an alternative to cash flows from operating activities determined in accordance with accounting principles generally accepted in the U.S. The Company’s leverage ratio for the twelve months ended September 30, 2014 was 1.5, which is below the maximum of 3.5 permitted under the Credit Agreement, and the interest coverage ratio for the twelve months ended September 30, 2014 was 30.0, which is above the minimum of 3.0 required under the Credit Agreement.

### New Accounting Pronouncements

In May 2014, the Financial Accounting Standards Board issued new guidance that clarifies the principles for recognizing revenue. The new guidance provides that an entity should recognize revenue for the transfer of goods or services equal to the amount that it expects to receive for those goods or services. The new guidance is effective for annual and interim periods beginning after December 15, 2016, and allows companies to apply the requirements retrospectively, either to all prior periods presented or through a cumulative adjustment in the year of adoption. Early adoption is not allowed. The Company is currently evaluating the impact, if any, that the adoption of the new guidance will have on its consolidated financial position, results of operations or cash flows.

There have been no other accounting pronouncements issued but not yet adopted by the Company which are expected to have a material impact on the Company’s consolidated financial position, results of operations or cash flows.

## Market risk

As filed, 3,233 characters.

### Market risk

#### Interest Rate Risk

The Company had outstanding total debt at September 30, 2014 of $1,053.7, of which 62% has a fixed weighted average interest rate of 3.06% and the remaining 38% constituted principally commercial paper issued by the Company that currently has an interest rate of less than 0.5%. The Company periodically considers entering into derivative financial instruments contracts to reduce interest rate risk exposure.

#### Diesel Fuel Hedges

The Company uses independent freight carriers to deliver its products. These carriers currently charge the Company a basic rate per mile that is currently subject to a mileage surcharge for diesel fuel price increases. During 2013 and 2014, the Company entered into hedge agreements with financial counterparties to mitigate the volatility of diesel fuel prices and related fuel surcharges, and not to speculate in the future price of diesel fuel. Under the hedge agreements, the Company agreed to pay a fixed price per gallon of diesel fuel determined at the time the agreements were executed and to receive a floating rate payment reflecting the variable common carriers’ mileage surcharge. The floating rate payment is determined on a monthly basis based on the average price of the Department of Energy’s Diesel Fuel Index during the applicable month and is designed to offset any increase or decrease in fuel surcharges that the Company pays to it common carriers. The agreements cover approximately 57% of the Company’s 2014 diesel fuel requirements and are expected to cover approximately 63% of the Company’s estimated diesel fuel requirements for 2015. These diesel fuel hedge agreements qualify for hedge accounting. Therefore, changes in the fair value of such agreements are recorded under Accumulated Other Comprehensive Income on the balance sheet.

#### Foreign Currency

The Company is subject to exposure from fluctuations in foreign currency exchange rates, primarily U.S. Dollar/Euro, U.S. Dollar/British Pound, U.S. Dollar/Canadian Dollar, U.S. Dollar/Mexican Peso, U.S. Dollar/Australian Dollar, U.S. Dollar/Brazilian Real and U.S. Dollar/Chinese Yuan.

The Company, from time to time, enters into forward exchange contracts to reduce the impact of foreign exchange rate fluctuations related to anticipated but not yet committed intercompany sales or purchases denominated in U.S. Dollar, Canadian Dollar, British Pound and Euro. The Company has entered into forward exchange contracts to protect itself from the risk that, due to changes in currency exchange rates, it would be adversely affected by net cash outflows.

#### Equity Derivatives

The Company has entered into equity derivative contracts covering its stock in order to minimize liability resulting from changes in the quoted fair values of such stock to participants in its Executive Deferred Compensation Plan who have investments under that Plan in a notional Company stock fund. These equity derivative contracts are typically settled in cash. Since the equity derivatives do not qualify for hedge accounting, the Company is required to mark the contracts to market throughout the life of the contracts and record changes in fair value in the consolidated statement of income.

## Controls and procedures

As filed, 4,806 characters.

a) Evaluation of Disclosure Controls and Procedures

The Company’s management, with the participation of the Company’s Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) at the end of the period covered by this report. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures, as of the end of the period covered by this report, are effective to provide reasonable assurance that the information required to be disclosed by the Company in reports filed under the Exchange Act is (i) recorded, processed, summarized and reported within the time periods specified in the rules and forms of the United States Securities and Exchange Commission (“the Commission”), and (ii) accumulated and communicated to the Company’s management, including the Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding the disclosure.

b) Change in Internal Control over Financial Reporting

No change in the Company’s internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) occurred during the Company’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

### CAUTIONARY NOTE ON FORWARD-LOOKING INFORMATION

This report contains forward-looking statements, including, among others, statements relating to sales and earnings growth; the effect of product mix; volume growth, including the effects of new product launches into new and existing categories; the impact of competitive actions in the laundry detergent category; other effects of competition; consumer demand and spending; earnings per share; gross margin changes; trade and marketing spending; marketing expense as a percentage of net sales; cost savings programs; the Company’s hedge programs; the impact of foreign exchange and commodity price fluctuations; the Company’s share repurchase programs; the effective tax rate; the impact of tax audits; tax changes; environmental and regulatory matters; the effect of the credit environment on the Company’s liquidity and capital expenditures; the Company’s fixed rate debt; compliance with the minimum interest coverage ratio requirement and the maximum leverage ratio requirement under the Credit Agreement; sufficiency of cash flows from operations; the Company’s current and anticipated future borrowing capacity to meet capital expenditure program costs; payment of dividends; actual and expected cash contributions to pension plans; and termination settlement expenses related to international pension plans. These statements represent the intentions, plans, expectations and beliefs of the Company, and are subject to risks, uncertainties and other factors, many of which are outside the Company’s control and could cause actual results to differ materially from such forward-looking statements. Factors that might cause such differences include a decline in market growth, retailer distribution and consumer demand (as a result of, among other things, political, economic and marketplace conditions and events); unanticipated increases in raw material and energy prices; adverse developments affecting the financial condition of major customers and suppliers; competition, including the entrance of The Procter & Gamble Company into the value detergent category; changes in marketing and promotional spending; growth or declines in various product categories and the impact of customer actions in response to changes in consumer demand and the economy, including increasing shelf space of private label products; consumer and competitor reaction to, and customer acceptance of, new product introductions and features; disruptions in the banking system and financial markets; foreign currency exchange rate fluctuations; the impact of natural disasters on the Company and its customers and suppliers, including third party information technology service providers; the acquisition or divestiture of assets; the outcome of contingencies, including litigation, pending regulatory proceedings and environmental matters; and changes in the regulatory environment.

The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by the U. S. federal securities laws. You are advised, however, to consult any further disclosures the Company makes on related subjects in its filings with the Commission.

## Risk factors

As filed, 252 characters.

In addition to the other information set forth in this report, you should carefully consider the factors discussed in Item 1A, “Risk Factors” in the Form 10-K, which could materially affect the Company’s business, financial condition or future results.

Filed Nov 3, 2014.
Source: SEC EDGAR, the filing index for accession 0001564590-14-004859. Last ingested by Listed: Nov 14, 2026, 21:34 ET. No prices; not investment advice.
